Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Blood|July 19, 2011
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemiaMatthew J Maurer, James R Cerhan, Jerry A Katzmann, et al.
International Journal of Molecular Epidemiology and Genetics|June 21, 2011
Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphomaJames R Cerhan, Zachary S Fredericksen, Alice H Wang, et al.
British Journal of Haematology|July 12, 2013
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patientsSameer A Parikh, Kari G Rabe, Timothy G Call, et al.
American Journal of Hematology|January 13, 2015
Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphomaSameer A Parikh, Thomas M Habermann, Kari G Chaffee, et al.
Cancer|April 9, 2014
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesTimothy G Call, Aaron D Norman, Curtis A Hanson, et al.
Leukemia|July 12, 2012
Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controlsJ Moreira, K G Rabe, J R Cerhan, et al.
The Journal of Biological Chemistry|December 14, 2012
ARHGAP21 protein, a new partner of α-tubulin involved in cell-cell adhesion formation and essential for epithelial-mesenchymal transitionKarin S A Barcellos, Carolina L Bigarella, Mark V Wagner, et al.
Blood|May 3, 2002
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasiaAyalew Tefferi, Ruben A Mesa, Leigh A Gray, et al.
Pageof 20